SLC13A3 and Canavan disease: Altered expression or function of SLC13A3 has also been associated with a reversible leukoencephalopathy [51], while its temporary ablation in a mouse model of Canavan disease was shown to reduce accumulation of N-acetylaspartate and to improve motor deficits [52].